EuPAT8: Eighth pan-European Science Conference on QbD and PAT Sciences 2016

The EuPAT8 will focus on PAT integration into pharmaceutical manufacturing, the biopharmaceutics risk assessment roadmap (BioRAM) for the integration of preclinical, clinical and pharmaceutical development including QbD for better products and QbD considerations for emerging therapies (biosimilars and nanomedicines). Technical, practical and regulatory challenges in each of these focus areas will be explored and debated in detail.